Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Grégory Verhoest"'
1
Cystectomy and ileal conduit for neurogenic bladder: Comparison of the open, laparoscopic and robotic approaches
Autor: Camille Haudebert, Juliette Hascoet, Lucas Freton, Zine‐eddine Khene, Gilles Dosin, Caroline Voiry, Emmanuelle Samson, Claire Richard, Anne‐Cécile Neau, Anais Drouet, Romain Mathieu, Karim Bensalah, Grégory Verhoest, Andréa Manunta, Benoit Peyronnet
Publikováno v: Neurourology and Urodynamics
Neurourology and Urodynamics, 2022, 41 (2), pp.601-608. ⟨10.1002/nau.24855⟩
International audience; Aim The objective of the present study was to compare the outcomes of open versus laparoscopic versus robotic cystectomy and ileal conduit for neurogenic lower urinary tract dysfunction (NLUTD). Methods The charts of all patie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a417c447fb039b77efc49f9a494f448
https://doi.org/10.1002/nau.24855
Zobrazit plný text záznamu
2
Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression
Autor: Solène-Florence, Kammerer-Jacquet, Camille, Gandon, Frederic, Dugay, Brigitte, Laguerre, Benoit, Peyronnet, Romain, Mathieu, Grégory, Verhoest, Karim, Bensalah, Xavier, Leroy, Sebastien, Aubert, Catherine, Vermaut, Fabienne, Escande, Virginie, Verkarre, Eva, Compérat, Damien, Ambrosetti, Florence, Pedeutour, Marc-Antoine, Belaud-Rotureau, Nathalie, Rioux-Leclercq
Publikováno v: Histopathology
Histopathology, 2022, 81 (2), pp.228-238. ⟨10.1111/his.14683⟩
International audience; Aims First described in 2014, renal cell carcinoma (RCC) with TFEB amplification (6p21) is a rare molecular subgroup whose diagnosis is challenging. The prognosis and therapeutic implications remain unclear. Methods We report
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dfb419aebb7aa3286b4ab6ee72ae3e5f
https://hal.science/hal-03711065
Zobrazit plný text záznamu
3
Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
Autor: Marine Charpentier, Charly Gutierrez, Thierry Guillaudeux, Grégory Verhoest, Rémy Pedeux
Publikováno v: Cancers
Cancers, MDPI, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, 2021, 13 (7), ⟨10.3390/cancers13071650⟩
Cancers, Vol 13, Iss 1650, p 1650 (2021)
Simple Summary Bladder cancer (BC) is the tenth most common cancer worldwide, with approximatively 550,000 new cases and 200,000 deaths in 2018. BC is divided into two subgroups: non-muscle invasive bladder cancer, an early stage of the cancer, and m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4c889c4be61bef7b3119f6ae4a749e18
https://hal.archives-ouvertes.fr/hal-03215764
Zobrazit plný text záznamu
6
Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential
Autor: Solène-Florence, Kammerer-Jacquet, Laurence, Crouzet, Angélique, Brunot, Julien, Dagher, Adélaïde, Pladys, Julien, Edeline, Brigitte, Laguerre, Benoit, Peyronnet, Romain, Mathieu, Grégory, Verhoest, Jean-Jacques, Patard, Alexandra, Lespagnol, Jean, Mosser, Marc, Denis, Yosra, Messai, Sophie, Gad-Lapiteau, Salem, Chouaib, Marc-Antoine, Belaud-Rotureau, Karim, Bensalah, Nathalie, Rioux-Leclercq
Publikováno v: International Journal of Cancer
International Journal of Cancer, 2017, 140 (1), pp.142-148. ⟨10.1002/ijc.30429⟩
International Journal of Cancer, Wiley, 2017, 140 (1), pp.142-148. ⟨10.1002/ijc.30429⟩
International audience; Clear cell renal cell carcinoma (ccRCC) is an aggressive tumor that is characterized in most cases by inactivation of the tumor suppressor gene VHL. The VHL/HIF/VEGF pathway thus plays a major role in angiogenesis and is curre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ff5097645fee7e7cbeb69da2e160560a
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01439352
Zobrazit plný text záznamu
7
Sunitinib Combined with Angiotensin-2 Type-1 Receptor Antagonists Induces More Necrosis: A Murine Xenograft Model of Renal Cell Carcinoma
Autor: Karim Bensalah, Cécile Vigneau, Audrey Lavenu, Marc-Antoine Belaud-Rotureau, Yannick Arlot-Bonnemains, Florence Jouan, Emmanuel Oger, Nathalie Rioux-Leclercq, Thibault Dolley-Hitze, Nicolas Collet, Grégory Verhoest
Publikováno v: BioMed Research International, Vol 2014 (2014)
BioMed Research International
BioMed Research International, 2014, 2014, pp.1-9. ⟨10.1155/2014/901371⟩
BioMed Research International, Hindawi Publishing Corporation, 2014, 2014, pp.1-9. ⟨10.1155/2014/901371⟩
Background. Angiotensin-2 type-1 receptor antagonists not are only antihypertensive drugs but also can inhibit VEGF production. We hypothesised that adding telmisartan to sunitinib could potentiate the antiangiogenic effects.Material and Methods. 786
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c348fbd74956b2534e6265fdcf34b9df
https://doaj.org/article/c5dab72a41054009bc5287c8d198cda5
Zobrazit plný text záznamu
8
Optical spectroscopy techniques can accurately distinguish benign and malignant renal tumours
Autor: Jean-Philippe, Couapel, Lotfi, Senhadji, Nathalie, Rioux-Leclercq, Grégory, Verhoest, Olivier, Lavastre, Renaud, de Crevoisier, Karim, Bensalah
Publikováno v: BJU international. 111(6)
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: There is little known about optical spectroscopy techniques ability to evaluate renal tumours. This study shows for the first time the ability of Raman and optical reflectance spectroscopy to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a720519bcda149eb9e141cdb7c4ec404
https://pubmed.ncbi.nlm.nih.gov/24120774
Zobrazit plný text záznamu
9
[Prognostic factors in localized and in metastatic renal cell carcinomas]
Autor: Jean-Jacques, Patard, Grégory, Verhoest, Stéphane, Culine
Publikováno v: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 17(5)
It is useful to dispose reliable prognostic factors in Renal Cell Carcinoma (RCC) for 3 major goals: providing patient information, designing rationale follow-up algorithms and selecting patients for adapted treatment schedules as well as new clinica
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::fc12d3368fcaa168c6b46b19e98d820c
https://pubmed.ncbi.nlm.nih.gov/17969787
Zobrazit plný text záznamu
10
[National prospective survey on the surgical quality of renal transplants in France. Study conducted by the Association Française d'Urologie Transplantation Committee]
Autor: Grégory, Verhoest, Laurent, Salomon, Benoît, Barrou, Karim, Bensalah, François, Guille, Bernard, Lobel, Jacques, Petit, Jean-Michel, Boutin, Jean-Luc, Descotes, Bertrand, Dore, Frédéric, Staerman, Gérard, Benoit, Lionel, Badet, Jacques, Hubert, Eric, Lechevallier, Jean-Jacques, Patard
Publikováno v: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 17(1)
The objective of this prospective study was to describe the nature of the lesions observed during brain-dead cadavre donor kidney harvesting in France and to identify the risk factors for these lesions.A questionnaire elaborated by the AFU Transplant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::081d8cd25bc6347563c5e27220682bcb
https://pubmed.ncbi.nlm.nih.gov/17373238
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje